Anderson Appointed to Potter-Lambert Chair in Cardiology
Mark E. Anderson, M.D., Ph.D., UI Hospitals and Clinics cardiac electrophysiologist and professor of internal medicine in the University of Iowa Roy J. and Lucille A. Carver College of Medicine, has been appointed to the Potter-Lambert Chair in Cardiology.
The chair was established through the UI Foundation by the Ralph B. Lambert estate in memory of Lambert's longtime friend Fred Potter. Lambert graduated from the UI in 1939 with a bachelor's degree in communications and theatre arts.
Anderson joined the UI faculty October 1 as director of the UI Division of Cardiology.
His research focuses on the biology of cardiac arrhythmias (abnormal heart rhythms) with the goal of developing therapies to counter this major cause of death in the United States. In particular, Anderson studies a signaling protein called calmodulin kinase II and the role it plays in heart arrhythmias and muscle enlargement. His clinical interests include devices and techniques such as pacemakers, defibrillators and catheter ablation that improve and rescue ailing hearts.
"Dr. Anderson is developing a national reputation as a physician-scientist and administrator in cardiology," said Paul Rothman, M.D., professor and head of the UI Department of Internal Medicine. "His appointment to the Potter-Lambert Chair in Cardiology will provide an additional boost to his ability to help realize the division's goals, particularly in building links between research and clinical care advances.
"We are grateful for the legacy left by Mr. Lambert that made this chair possible," Rothman added.
Anderson's research honors include an Established Investigator Award from the American Heart Association and election to the American Society of Clinical Investigation. He has authored numerous papers and other writings, and serves on the editorial board of the Journal of Cardiovascular Electrophysiology.
Anderson earned a medical degree and a doctoral degree in physiology from the University of Minnesota. At Stanford University, he then completed an internship and residency in internal medicine, and fellowships in cardiology and clinical cardiac electrophysiology. In 1996, he joined the faculty of Vanderbilt University, where his recent positions included the Jack and Betty Bailey Professor of Cardiology, professor of medicine and pharmacology, director of the Electrophysiology Fellowship Training Program, director of the Cardiovascular Fellowship Training Program and director of Arrhythmia Services.
Cohen Appointed to Richard G. Lynch Chair in Experimental Pathology
Michael B. Cohen, M.D., professor and head of pathology in the University of Iowa Roy J. and Lucille A. Carver College of Medicine, has been named the first Dr. Richard G. Lynch Chair in Experimental Pathology.
The chair honors Richard Lynch, M.D., the emeritus Clement T. and Sylvia H. Hanson Family Professor of Immunology and UI professor emeritus of pathology, and was established in recognition of Lynch's many contributions as an academic leader for the Department of Pathology and the UI Carver College of Medicine. The chair is attached to the departmental headship.
Lynch, an internationally recognized experimental immunologist, was head of pathology at the UI for nearly 20 years. He also served as interim dean of the College of Medicine from 1993 to 1994. Lynch currently is a professor emeritus in the department and continues to teach.
"Dr. Lynch is a valued and influential leader who has served his field, the college and the broader biomedical community with great distinction for well over two decades," said Jean Robillard, M.D., dean of the UI Carver College of Medicine. "Dr. Cohen is a distinguished clinician scientist in the same mold. Like Dr. Lynch, he is a national leader in investigative pathology who has made outstanding contributions to research and education. It is most fitting that Michael Cohen has been named to a professorship honoring Richard Lynch."
Cohen is an internationally renowned diagnostic cytopathologist and urologic pathologist. His research on prostate cancer biology involves understanding mechanisms of apoptosis (programmed cell suicide) in prostate cancer. He has served on editorial boards of numerous academic journals, including Clinical Cancer Research, and has been a member of the executive board of the American Society of Cytopathology and the council of the American Society of Investigative Pathology.
Cohen received a medical degree from Albany Medical College and completed a medical internship at Albany Medical Center Hospital. Subsequently, he also completed a pathology residency and cytology fellowship at the University of California, San Francisco. Cohen joined the UI faculty in 1990 and became head of pathology in 1999.
Lynch received a medical degree from the University of Rochester in 1966 and completed a pathology residency and fellowship at Washington University. His research focused on cancer immunology. He is a past president of the American Society for Investigative Pathology, has served on the board of the Federation of American Societies for Experimental Biology (FASEB) and has served as a peer reviewer for the National Institutes of Health for 25 years.
|
